Optic nerve micro-stimulation

Optic nerve micro-stimulation
Howard Larkin
Howard Larkin
Published: Saturday, November 14, 2020
Bernhard A Sabel PhD
Visual field defects can be reversed by reactivating “silent” neurons using electronic micro-stimulation of the eyes and brain, Prof Bernhard A Sabel PhD told AAO 2020 Virtual. Prof Sabel, of Otto-von-Guericke University, Magdeburg, Germany, described a device that delivers electrical pulses through pads at the temple and above the eyes. Stimulation travels through the eye and the optic nerved to the brain’s frontal cortex, 40 minutes per day for 10 days. In a clinical trial involving 623 patients, 84% experienced an increase in visual field size averaging 24%, with 60% better vision in the impaired visual sector. Response is highly variable with one patient’s visual field index improved from 19% to 63%. (Gail, Sabel et al. PLoS ONE 2016). The improvement cannot be explained by the growth of new cells or rescuing cells from death, Prof Sabel said. Rather, it likely is due to reactivation of hypo-metabolic “silent” neurons, which survive the disease. Evidence for this reactivation includes changes in brain function with increased messaging from the occipital cortex to the frontal cortex after stimulation, as well as increased brain oxygenation in these areas. Electronic stimulation increases the potential for neurons firing, releasing potassium that stimulates dilation of the blood vessels, increasing blood supply, Prof Sabel explained. This may help reactivate cells rendered dormant through vascular dysfunction. This technique has the potential to reverse not only glaucoma, but also optic nerve damage and retinal trauma, diabetic neuropathy, vision loss after stroke or brain trauma, and macular degeneration, Dr Sabel said.
Tags: AAO Virtual 2020
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...